# OnCo record e1910 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/e1910/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "e1910", "NCT02003222" ;
  schema:name "ECOG-ACRIN E1910"@en ;
  schema:description "Proved that adding the immunotherapy blinatumomab to standard treatment saves lives even in patients whose leukaemia was already undetectable."@en ;
  schema:url <https://onco.cc/trials/e1910/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02003222>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2312948> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2014-05-19" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/aya-cancers/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:companies <https://onco.cc/companies/ecog-acrin/> ;
  onco:terms <https://onco.cc/terms/mrd-negative-cr/> ;
  onco:people <https://onco.cc/people/mark-litzow/> .